SS: A well-reasoned assessment. Emphasis upon lung surgery by LTC is spot on. Apparently, this is where LTC shuts the competition down all hallow. Alas, FDA has not yet approved electrosurgery of any kind on lung tissue given the issue of smoke. Thus, smokeless LTC is the answer, though its approved use in the application will likely require clinical studies. Meanwhile, there are LTC surgeries that can proceed without further ado by FDA or EU. The question of timeline also begs. FWIW, my gut feeling is that announcement of new LTC managment team is close on. Once team is emplaced, one could speculate with some measure of confidence that refitted LTC will attract renewed attention of medical device firms seeking licenses or more. The issue of patent ownership need not bedevil us. The keen parties to the negotiations arguably are comfortable with current licensing arrangement. Perforce of logic, they wouldn't be sitting there otherwise.
CTGI
These are only my opinions and sentiments, not an endorsement to buy or sell anything. Buying stocks is risky; you could lose all of your investment. Always do your DD.
Buying gold won't save your soul, but it could save your skin one day.
